Novel antibodies to erbB2 which inhibit the growth of tumor cell lines expressing varying levels of receptor

被引：0
|
作者：
Cartlidge, Susan
Dong, Jianying
Babcook, John
Kang, Jaspal
Foltz, Ian
Veldman-Jones, Margaret
Vincent, John
Blakey, David
机构：
[1] AstraZeneca, Macclesfield, Cheshire, England
[2] Abgenix Inc, Fremont, CA USA
[3] Amgen British Columbia, Burnaby, BC, Canada
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
831
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Intermittent hypoxia induces the proliferation of rat vascular smooth muscle cell with the increases in epidermal growth factor family and erbB2 receptor
    Kyotani, Yoji
    Ota, Hiroyo
    Itaya-Hironaka, Asako
    Yamauchi, Akiyo
    Sakuramoto-Tsuchida, Sumiyo
    Zhao, Jing
    Ozawa, Kentaro
    Nagayama, Kosuke
    Ito, Satoyasu
    Takasawa, Shin
    Kimura, Hiroshi
    Uno, Masayuki
    Yoshizumi, Masanori
    EXPERIMENTAL CELL RESEARCH, 2013, 319 (19) : 3042 - 3050
  • [42] Mediator of ERBB2-driven Cell Motility (MEMO) Promotes Extranuclear Estrogen Receptor Signaling Involving the Growth Factor Receptors IGF1R and ERBB2
    Jiang, Kai
    Yang, Zhihong
    Cheng, Long
    Wang, Shibin
    Ning, Kang
    Zhou, Lei
    Lin, Jing
    Zhong, Hui
    Wang, Lisheng
    Li, Yang
    Huang, Junjian
    Zhang, Hao
    Ye, Qinong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (34) : 24590 - 24599
  • [43] Gene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptor
    Klaus Stensgaard Frederiksen
    Niels Abrahamsen
    Richard J Cristiano
    Lars Damstrup
    Hans Skovgaard Poulsen
    Cancer Gene Therapy, 2000, 7 : 262 - 268
  • [44] Gene delivery by an epidermal growth factor/DNA polyplex to small cell lung cancer cell lines expressing low levels of epidermal growth factor receptor
    Frederiksen, KS
    Abrahamsen, N
    Cristiano, RJ
    Damstrup, L
    Poulsen, HS
    CANCER GENE THERAPY, 2000, 7 (02) : 262 - 268
  • [45] Toxicity of 90Y-Theraloc® in cultured human tumor cell lines expressing the epidermal growth factor receptor (EGFR)
    Beckford, Vera D. R.
    Eigner, S.
    Eigner, Henke K.
    Beran, M.
    Melichar, F.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S565 - S565
  • [46] ESTROGEN-RECEPTOR LEVELS AND TUMOR-GROWTH IN A SERIES OF PITUITARY CLONAL CELL-LINES IN RATS
    FUJIMOTO, N
    WATANABE, H
    ITO, A
    INOUE, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 1991, 82 (12): : 1436 - 1441
  • [47] Defining the Sister Rat Mammary Tumor Cell Lines HH-16 cl.2/1 and HH-16.cl.4 as an In Vitro Cell Model for Erbb2
    Louzada, Sandra
    Adega, Filomena
    Chaves, Raquel
    PLOS ONE, 2012, 7 (01): : 206 - 220
  • [48] Nonisotopic quantitation of mRNA using a novel RNase protection assay: Measurement of erbB-2 mRNA in tumor cell lines
    Chan, SDH
    Dill, K
    Blomdahl, J
    Wada, HG
    ANALYTICAL BIOCHEMISTRY, 1996, 242 (02) : 214 - 220
  • [49] Carbonate apatite nanoparticles carry siRNA(s) targeting growth factor receptor genes egfr1 and erbb2 to regress mouse breast tumor
    Tiash, Snigdha
    Kamaruzman, Nur Izyani Binti
    Chowdhury, Ezharul Hoque
    DRUG DELIVERY, 2017, 24 (01) : 1721 - 1730
  • [50] A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2
    Biburger, M
    Weth, R
    Wels, WS
    JOURNAL OF MOLECULAR BIOLOGY, 2005, 346 (05) : 1299 - 1311
12345